Cargando…

Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study

Background. Primaquine is used to eradicate latent Plasmodium vivax parasite from liver, with administration of standard dose daily up to 14 days. We studied efficacy, safety, and tolerability of sustained release (SR) formulation of primaquine in comparison with conventional primaquine in preventin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pareek, Anil, Chandurkar, Nitin, Gogtay, Nithya, Deshpande, Alaka, Kakrani, Arjun, Kaneria, Mala, Karmakar, Partha, Jain, Arvind, Kochar, Dhanpat, Chogle, Arun, Ray, Arnab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558454/ https://www.ncbi.nlm.nih.gov/pubmed/26366319 http://dx.doi.org/10.1155/2015/579864

Ejemplares similares

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
por: Rajgor, D. D., et al.
Publicado: (2014)

Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005)

Pharmacokinetics of single-dose primaquine in patients with chronic kidney dysfunction
por: Kulkarni, Shaunak P., et al.
Publicado: (2013)

Evaluation of pharmacokinetics of single-dose primaquine in undernourished versus normally nourished children diagnosed with Plasmodium vivax malaria in Mumbai
por: Gogtay, NJ, et al.
Publicado: (2021)

A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
por: Gogtay, NJ, et al.
Publicado: (2006)

Primaquine in vivax malaria: an update and review on management issues
por: Fernando, Deepika, et al.
Publicado: (2011)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
por: Reddy, Pavani, et al.
Publicado: (2006)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Population pharmacokinetics of primaquine and the effect of hepatic and renal dysfunction: An exploratory approach
por: Sridharan, Kannan, et al.
Publicado: (2019)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
por: Taylor, Walter R J, et al.
Publicado: (2019)

Mass primaquine treatment to eliminate vivax malaria: lessons from the past
por: Kondrashin, Anatoly, et al.
Publicado: (2014)

Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
por: Bright, A. Taylor, et al.
Publicado: (2013)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

Clinical Proteomics of the Neglected Human Malarial Parasite Plasmodium vivax
por: Acharya, Pragyan, et al.
Publicado: (2011)

Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon
por: Graf, Paul C. F., et al.
Publicado: (2012)

Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
por: Heidari, Aliehsan, et al.
Publicado: (2012)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin
por: Mello, Amanda Gabryelle Nunes Cardoso, et al.
Publicado: (2018)

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2019)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Absence of gender influence on the pharmacokinetics of chloroquine combined with primaquine in malaria vivax patients
por: Vieira, Michelle Valeria Dias Ferreira, et al.
Publicado: (2020)

The effect of SNPs in CYP450 in chloroquine/primaquine Plasmodium vivax malaria treatment
por: Sortica, Vinicius A, et al.
Publicado: (2016)

Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India
por: Anvikar, Anupkumar R., et al.
Publicado: (2022)

Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study
por: Valecha, Neena, et al.
Publicado: (2016)

Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India
por: Siqueira, André M, et al.
Publicado: (2015)

Adherence to 7-Day Primaquine Treatment for the Radical Cure of P. vivax in the Peruvian Amazon
por: Grietens, Koen Peeters, et al.
Publicado: (2010)

Dynamics of P. vivax clones in a cohort of children with or without primaquine treatment at baseline
por: Wampfler, Rahel, et al.
Publicado: (2014)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum
por: Wampfler, Rahel, et al.
Publicado: (2017)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
por: Taylor, Walter Robert, et al.
Publicado: (2021)

Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
por: Popovici, Jean, et al.
Publicado: (2021)

Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria
por: Ray, Sandipan, et al.
Publicado: (2016)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine
por: Chamnanphon, Monpat, et al.
Publicado: (2020)

Relapse of Plasmodium vivax and Plasmodium ovale Malaria With and Without Primaquine Treatment in a Nonendemic Area
por: Wångdahl, Andreas, et al.
Publicado: (2021)

Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
por: Rahi, Manju, et al.
Publicado: (2023)

Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_torfpa20v9f5k7q5ugeq4c6flj